Cory Berkland

Prof. Cory Berkland

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2008 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
LPLaura J. Peek
Laura J. Peek
CMC. Russell Middaugh
C. Russell Middaugh
CBCory Berkland
Cory Berkland

29 December 2017 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
CPChad J. Pickens
Chad J. Pickens
SJStephanie N. Johnson
Stephanie N. Johnson
MPMelissa M. Pressnall
Melissa M. Pressnall
MLMartin A. Leon
Martin A. Leon
CBCory Berkland
Cory Berkland

27 October 2008 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
MBMark M. Bailey
Mark M. Bailey
CBCory Berkland
Cory Berkland

13 November 2007 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
NZNa Zhang
Na Zhang
CCChuda Chittasupho
Chuda Chittasupho
CDChadarat Duangrat
Chadarat Duangrat
TSTeruna J. Siahaan
Teruna J. Siahaan
CBCory Berkland
Cory Berkland

1 June 2010 in Biomaterials
Verified
Journal Article
Open access
QWQun Wang
Qun Wang
JWJinxi Wang
Jinxi Wang
QLQinghua Lu
Qinghua Lu
MDMichael Scott Detamore
Michael Scott Detamore
CBCory Berkland
Cory Berkland
Bone fillers have emerged as an alternative to the invasive surgery often required to repair skeletal defects. Achieving controlled release from these materials is desired for accelerating healing. Here, oppositely-charged Poly (D,L-lactic-co-glycolic acid) (PLGA) nanoparticles were used to create a cohesive colloidal gel as an injectable drug-loaded filler to promote healing in bone defects. The colloid self-assembled through electrostatic forces resulting in a stable 3-D network that may be extruded or molded to the desired shape. The colloidal gel demonstrated shear-thinning behavior due to the disruption of interparticle interactions as the applied shear force was increased. Once the external force was removed, the cohesive property of the colloidal gel was recovered. Similar reversibility and shear-thinning behavior were also observed in colloidal gels loaded with dexamethasone. Near zero-order dexamethasone release was observed over two months when the drug was encapsulated in PLGA nanoparticles and simply blending the drug with the colloidal gel showed similar kinetics for one month. Surgical placement was facilitated by the pseudoplastic material properties and in vivo observations demonstrated that the PLGA colloidal gels stimulated osteoconductive bone formation in rat cranial bone defects.